SAMSUNG PHARM. Co., LTD.
KRX:001360.KS
1518 (KRW) • At close January 15, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) KRW.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 51,955.038 | 51,832.234 | 54,901.13 | 48,269.172 | 44,566.363 | 46,483.649 | 41,919.469 | 48,223.43 | 42,164.637 | 30,287.782 | 46,920.575 | 47,285.859 | 44,078.653 | 39,243.911 | 37,057.787 | 33,236.504 | 32,802.727 |
| Cost of Revenue
| 28,981.967 | 27,213.215 | 45,619.392 | 37,818.278 | 35,167.193 | 37,894.3 | 36,837.63 | 40,614.196 | 30,893.9 | 21,789.267 | 29,522.306 | 28,148.717 | 26,132.967 | 22,617.596 | 22,434.545 | 19,617.103 | 19,578.573 |
| Gross Profit
| 22,973.071 | 24,619.018 | 9,281.738 | 10,450.894 | 9,399.17 | 8,589.349 | 5,081.839 | 7,609.234 | 11,270.738 | 8,498.515 | 17,398.269 | 19,137.142 | 17,945.686 | 16,626.315 | 14,623.242 | 13,619.401 | 13,224.154 |
| Gross Profit Ratio
| 0.442 | 0.475 | 0.169 | 0.217 | 0.211 | 0.185 | 0.121 | 0.158 | 0.267 | 0.281 | 0.371 | 0.405 | 0.407 | 0.424 | 0.395 | 0.41 | 0.403 |
| Reseach & Development Expenses
| 2,279.208 | 327.02 | 650.536 | 663.578 | 90.931 | 377.508 | 938.791 | 926.542 | 296.667 | 5.832 | 3 | 55 | 74 | 289.179 | 34.321 | 50.672 | 95.309 |
| General & Administrative Expenses
| 1,038.894 | 1,184.958 | 929.05 | 1,078.698 | 1,331.5 | 1,474.932 | 1,370.533 | 1,953.465 | 1,894.255 | 2,899.969 | 4,012.102 | 3,607.54 | 4,072.763 | 3,651.583 | 3,337.938 | 2,281.022 | 2,204.356 |
| Selling & Marketing Expenses
| 32,289.26 | 31,500.069 | 19,523.843 | 9,709.28 | 3,483.527 | 4,071.035 | 2,242.824 | 6,882.414 | 4,415.998 | 1,288.266 | 3,283 | 4,957 | 2,503 | 1,497.663 | 1,701.583 | 1,761.83 | 3,698.995 |
| SG&A
| 33,328.154 | 32,685.027 | 20,452.893 | 10,787.978 | 4,815.027 | 5,545.967 | 3,613.357 | 8,835.879 | 6,310.253 | 4,188.235 | 7,295.102 | 8,564.54 | 6,575.763 | 5,149.246 | 5,039.521 | 4,042.852 | 5,903.351 |
| Other Expenses
| 5,402.779 | 5,568.148 | 6,318.14 | 8,796.084 | 9,714.319 | 7,449.529 | -1,764.637 | -4,859.882 | 2,253.462 | -1,453.071 | -4,370.446 | -420.397 | -175.625 | -1,405.277 | 2,573.54 | 77.14 | -657.89 |
| Operating Expenses
| 41,010.141 | 38,580.195 | 27,421.569 | 20,247.64 | 14,620.277 | 13,373.004 | 11,962.067 | 17,197.445 | 13,141.222 | 28,318.481 | 28,816.102 | 18,601.54 | 17,489.763 | 14,361.024 | 14,365.805 | 11,575.596 | 13,576.575 |
| Operating Income
| -18,042.52 | -13,961.177 | -18,139.831 | -9,796.746 | -5,221.107 | -3,265.417 | -6,880.226 | -9,588.212 | -1,870.484 | -19,819.967 | -11,417.834 | 541.602 | 455.923 | 2,265.291 | 257.44 | 2,043.806 | -352.424 |
| Operating Income Ratio
| -0.347 | -0.269 | -0.33 | -0.203 | -0.117 | -0.07 | -0.164 | -0.199 | -0.044 | -0.654 | -0.243 | 0.011 | 0.01 | 0.058 | 0.007 | 0.061 | -0.011 |
| Total Other Income Expenses Net
| -5,632.397 | -11,131.854 | -22,136.512 | -29,832.838 | 13,558.258 | 2,767.5 | -3,822.749 | -11,021.098 | 1,216.637 | -3,928.214 | -7,070.956 | -3,667.854 | -2,203.948 | -3,171.521 | 1,059.071 | -1,530.597 | -2,004.426 |
| Income Before Tax
| -23,674.917 | -25,093.031 | -40,276.344 | -39,876.979 | 7,086.836 | -2,016.152 | -10,965.931 | -22,041.661 | -653.847 | -23,748.181 | -18,488.79 | -3,132.252 | -1,748.025 | -906.23 | 1,316.511 | 513.209 | -2,356.85 |
| Income Before Tax Ratio
| -0.456 | -0.484 | -0.734 | -0.826 | 0.159 | -0.043 | -0.262 | -0.457 | -0.016 | -0.784 | -0.394 | -0.066 | -0.04 | -0.023 | 0.036 | 0.015 | -0.072 |
| Income Tax Expense
| 1,137.105 | 11,860.632 | 22,401.75 | 23,887.034 | 201.663 | 59.554 | -3,691.97 | -424.057 | 340.545 | -1,442.98 | -4,357.956 | -342.104 | -109.743 | -1,353.998 | 2,615.349 | -121 | -462.8 |
| Net Income
| -24,812.022 | -36,953.663 | -62,678.094 | -63,764.013 | 6,885.174 | -2,075.706 | -7,539.888 | -21,617.603 | -994.386 | -23,748.181 | -18,488.79 | -3,132.252 | -1,748.025 | -906.23 | 1,316.511 | 634.209 | -2,356.85 |
| Net Income Ratio
| -0.478 | -0.713 | -1.142 | -1.321 | 0.154 | -0.045 | -0.18 | -0.448 | -0.024 | -0.784 | -0.394 | -0.066 | -0.04 | -0.023 | 0.036 | 0.019 | -0.072 |
| EPS
| -333.83 | -496.74 | -852.31 | -941.87 | 106.06 | -40.51 | -172.88 | -603.7 | -33.28 | -1,112.91 | -1,424.43 | -332 | -197.65 | -102.42 | 148.5 | 71.69 | -266.28 |
| EPS Diluted
| -333.83 | -496.74 | -852.31 | -941.87 | 106.06 | -40.51 | -172.88 | -603.7 | -33.28 | -1,112.91 | -1,424.43 | -332 | -197.65 | -102.42 | 148.5 | 71.69 | -266.28 |
| EBITDA
| -21,687.797 | -21,974.515 | -36,459.623 | -25,323.47 | 12,424.614 | 3,104.529 | -4,460.454 | -11,575.835 | 3,006.152 | -20,789.504 | -14,410.54 | 1,203.747 | 1,466.791 | 1,954.305 | 4,000.515 | 3,307.13 | 291 |
| EBITDA Ratio
| -0.417 | -0.195 | -0.267 | -0.244 | -0.039 | 0.011 | -0.097 | -0.206 | 0.071 | -0.653 | -0.307 | 0.028 | 0.033 | 0.05 | 0.108 | 0.1 | 0.007 |